| European Case Law Identifier: | ECLI:EP:BA:2014:T145709.20140117 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 17 January 2014 | ||||||||
| Case number: | T 1457/09 | ||||||||
| Application number: | 99952682.5 | ||||||||
| IPC class: | C07K 14/47 C07K 4/12 C07K 7/06 A61K 38/087 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Immunotherapeutic methods using epitopes of WT-1 and GATA-1 | ||||||||
| Applicant name: | Ganymed Pharmaceuticals AG | ||||||||
| Opponent name: | Dainippon Sumitomo Pharma Co., Ltd. | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request - after amendment: requirements of the EPC met (yes) | ||||||||
| Catchwords: |
See points 34 to 46 |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t091457eu1.html
Date retrieved: 17 May 2021